AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
More Good News For Genentech
Genentech reported that its drug Herceptin can cut recurrence of a type of breast cancer that accounts for 25% of all cases. The stock gapped up, capping off a 60% gain since mid-March, when good results started to come in for the firm's various cancer drugs.
Medco Falls, Express Gains On Q1
Medco Health Solutions said Q1 profit rose 19% from the prior year to 57 cents a share; sales fell 2%. The stock dropped about 9%. Shares of fellow pharmacy benefit manager Express Scripts rose 5% as profit gained 26%, though sales also came in slightly below views at $3.8 billion.
...